VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 29, 2008) - Pacgen Biopharmaceuticals Corporation (“Pacgen” or the “Company”) (TSX VENTURE: PGA) today reported financial results from its fiscal year ended March 31, 2008. Amounts unless specified otherwise, are expressed in Canadian dollars and in accordance with Canadian Generally Accepted Accounting Principles (Canadian GAAP).
